• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA损伤调节微小RNA与26S蛋白酶体之间的相互作用。

DNA damage modulates interactions between microRNAs and the 26S proteasome.

作者信息

Tsimokha Anna S, Kulichkova Valentina A, Karpova Elena V, Zaykova Julia J, Aksenov Nikolai D, Vasilishina Anastasia A, Kropotov Andrei V, Antonov Alexey, Barlev Nikolai A

机构信息

Institute of Cytology, Russian Academy of Sciences, 194064 St. Petersburg, Russia.

Institute of Cytology, Russian Academy of Sciences, 194064 St. Petersburg, Russia; Department of Biochemistry, University of Leicester, Leicester, LE1 9HN; Molecular Pharmacology laboratory, Saint-Petersburg Institute of Technology, Saint-Petersburg 190013, Russia.

出版信息

Oncotarget. 2014 Jun 15;5(11):3555-67. doi: 10.18632/oncotarget.1957.

DOI:10.18632/oncotarget.1957
PMID:25004448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4116502/
Abstract

26S proteasomes are known as major non-lysosomal cellular machines for coordinated and specific destruction of ubiquitinylated proteins. The proteolytic activities of proteasomes are controlled by various post-translational modifications in response to environmental cues, including DNA damage. Besides proteolysis, proteasomes also associate with RNA hydrolysis and splicing. Here, we extend the functional diversity of proteasomes by showing that they also dynamically associate with microRNAs (miRNAs) both in the nucleus and cytoplasm of cells. Moreover, DNA damage induced by an anti-cancer drug, doxorubicin, alters the repertoire of proteasome-associated miRNAs, enriching the population of miRNAs that target cell cycle checkpoint regulators and DNA repair proteins. Collectively, these data uncover yet another potential mode of action for proteasomes in the cell via their dynamic association with microRNAs.

摘要

26S蛋白酶体是已知的主要非溶酶体细胞机器,用于协调和特异性降解泛素化蛋白。蛋白酶体的蛋白水解活性受各种翻译后修饰的控制,以响应包括DNA损伤在内的环境信号。除了蛋白水解作用外,蛋白酶体还与RNA水解和剪接相关。在这里,我们通过表明蛋白酶体在细胞核和细胞质中均与微小RNA(miRNA)动态结合,扩展了蛋白酶体的功能多样性。此外,抗癌药物阿霉素诱导的DNA损伤改变了蛋白酶体相关miRNA的种类,增加了靶向细胞周期检查点调节因子和DNA修复蛋白的miRNA数量。总体而言,这些数据揭示了蛋白酶体通过与微小RNA的动态结合在细胞中的另一种潜在作用方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/929ee6bcd359/oncotarget-05-3555-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/d3fbc9b9bf23/oncotarget-05-3555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/02a112db1dbd/oncotarget-05-3555-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/5406ca11dfd8/oncotarget-05-3555-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/c3f5b83fa0d4/oncotarget-05-3555-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/64b4251ab7e7/oncotarget-05-3555-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/929ee6bcd359/oncotarget-05-3555-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/d3fbc9b9bf23/oncotarget-05-3555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/02a112db1dbd/oncotarget-05-3555-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/5406ca11dfd8/oncotarget-05-3555-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/c3f5b83fa0d4/oncotarget-05-3555-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/64b4251ab7e7/oncotarget-05-3555-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/4116502/929ee6bcd359/oncotarget-05-3555-g006.jpg

相似文献

1
DNA damage modulates interactions between microRNAs and the 26S proteasome.DNA损伤调节微小RNA与26S蛋白酶体之间的相互作用。
Oncotarget. 2014 Jun 15;5(11):3555-67. doi: 10.18632/oncotarget.1957.
2
DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.DNA损伤诱导的蛋白酶体泛素化调控其蛋白水解活性。
Oncotarget. 2013 Sep;4(9):1338-48. doi: 10.18632/oncotarget.1060.
3
Changes in composition and activities of 26S proteasomes under the action of doxorubicin--apoptosis inductor of erythroleukemic K562 cells.阿霉素(红白血病K562细胞凋亡诱导剂)作用下26S蛋白酶体的组成和活性变化
Cell Biol Int. 2007 Apr;31(4):338-48. doi: 10.1016/j.cellbi.2007.01.018. Epub 2007 Jan 21.
4
[Specificity of changes in proteasome properties in diethylmaleate-induced apoptosis of K562 cells].[马来酸二乙酯诱导K562细胞凋亡过程中蛋白酶体特性变化的特异性]
Tsitologiia. 2006;48(2):133-41.
5
[Reprogramming of nuclear proteasomes in K562 cells undergoing apoptosis. II. Effect of anticancer drug doxorubicin].[K562细胞凋亡过程中核蛋白酶体的重编程。II. 抗癌药物阿霉素的作用]
Tsitologiia. 2007;49(7):552-60.
6
HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress.HSP70 介导 26S 蛋白酶体在氧化应激适应过程中的解聚和再组装。
Free Radic Biol Med. 2011 Oct 1;51(7):1355-64. doi: 10.1016/j.freeradbiomed.2011.06.015. Epub 2011 Jun 24.
7
Effect of ubiquitination on peptidase activities of proteasomes in genotoxic stress.泛素化对基因毒性应激中蛋白酶体肽酶活性的影响。
Dokl Biochem Biophys. 2010 Nov-Dec;435:307-11. doi: 10.1134/S1607672910060074. Epub 2010 Dec 24.
8
Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.硼替佐米联合多柔比星治疗多发性骨髓瘤细胞改变 20S 蛋白酶体的互作组。
Cell Cycle. 2018;17(14):1745-1756. doi: 10.1080/15384101.2018.1496742. Epub 2018 Aug 1.
9
[Selective effect of inductors of apoptosis on the endoribonuclease activity of 26S proteasomes and alpha-RNP particles in K562 cells: possible involvement of 26S proteasomes and alpha-RNP in the regulation of RNA stability].[凋亡诱导剂对K562细胞中26S蛋白酶体和α-核糖核蛋白颗粒核糖核酸内切酶活性的选择性作用:26S蛋白酶体和α-核糖核蛋白可能参与RNA稳定性的调节]
Tsitologiia. 2004;46(3):283-90.
10
[Mass spectrometric analysis of proteasomes affinity puirified from the human myelogenous leukemia cells K562].[从人髓性白血病细胞K562亲和纯化的蛋白酶体的质谱分析]
Bioorg Khim. 2014 Nov-Dec;40(6):720-34. doi: 10.1134/s1068162014060041.

引用本文的文献

1
Ubiquitin recruiting chimera: more than just a PROTAC.泛素招募嵌合体:不只是一个 PROTAC。
Biol Direct. 2024 Jul 9;19(1):55. doi: 10.1186/s13062-024-00497-8.
2
The Role of E3 Ligase Pirh2 in Disease.E3 连接酶 Pirh2 在疾病中的作用。
Cells. 2022 Apr 30;11(9):1515. doi: 10.3390/cells11091515.
3
Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells.癌-睾丸抗原、精液凝胶蛋白1和2对人肺腺癌细胞表现出不同的抗增殖作用。

本文引用的文献

1
miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.miR-16 和 miR-26a 通过响应基因毒性应激激活 p53 ,靶向细胞检查点激酶 Wee1 和 Chk1。
Cell Death Dis. 2013 Dec 12;4(12):e953. doi: 10.1038/cddis.2013.483.
2
Lysine-specific modifications of p53: a matter of life and death?p53的赖氨酸特异性修饰:生死攸关之事?
Oncotarget. 2013 Oct;4(10):1556-71. doi: 10.18632/oncotarget.1436.
3
DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.DNA损伤诱导的蛋白酶体泛素化调控其蛋白水解活性。
Cell Death Discov. 2020 Oct 22;6:108. doi: 10.1038/s41420-020-00336-5. eCollection 2020.
4
Post-Translational Modifications of Extracellular Proteasome.细胞外蛋白酶体的翻译后修饰。
Molecules. 2020 Jul 31;25(15):3504. doi: 10.3390/molecules25153504.
5
Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.硼替佐米联合多柔比星治疗多发性骨髓瘤细胞改变 20S 蛋白酶体的互作组。
Cell Cycle. 2018;17(14):1745-1756. doi: 10.1080/15384101.2018.1496742. Epub 2018 Aug 1.
6
Proteomic analysis of affinity-purified extracellular proteasomes reveals exclusively 20S complexes.亲和纯化的细胞外蛋白酶体的蛋白质组学分析仅揭示了20S复合物。
Oncotarget. 2017 Nov 1;8(60):102134-102149. doi: 10.18632/oncotarget.22230. eCollection 2017 Nov 24.
7
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.一碳代谢和核苷酸生物合成作为抗癌治疗的有吸引力的靶点。
Oncotarget. 2017 Apr 4;8(14):23955-23977. doi: 10.18632/oncotarget.15053.
8
Lovastatin upregulates microRNA-29b to reduce oxidative stress in rats with multiple cardiovascular risk factors.洛伐他汀上调微小RNA-29b以减轻具有多种心血管危险因素大鼠的氧化应激。
Oncotarget. 2017 Feb 7;8(6):9021-9034. doi: 10.18632/oncotarget.14462.
9
miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL.微小RNA143通过下调BCR-ABL诱导K562细胞凋亡。
Med Sci Monit. 2016 Aug 5;22:2761-7. doi: 10.12659/msm.895833.
10
Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.血红素诱导分化后红白血病K562中α型蛋白酶体亚基核糖核酸内切酶活性的调控
Protein J. 2016 Feb;35(1):17-23. doi: 10.1007/s10930-015-9642-x.
Oncotarget. 2013 Sep;4(9):1338-48. doi: 10.18632/oncotarget.1060.
4
The nucleolus stress response is coupled to an ATR-Chk1-mediated G2 arrest.核仁应激反应与 ATR-Chk1 介导的 G2 期阻滞相偶联。
Mol Biol Cell. 2013 May;24(9):1334-42. doi: 10.1091/mbc.E12-12-0881. Epub 2013 Feb 27.
5
Therapeutic targeting of cancer cell cycle using proteasome inhibitors.利用蛋白酶体抑制剂靶向治疗癌细胞周期。
Cell Div. 2012 Dec 26;7(1):26. doi: 10.1186/1747-1028-7-26.
6
MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets.MIRUMIR:一种在线工具,用于使用多个临床数据集测试作为预测癌症生存生物标志物的微小RNA。
Cell Death Differ. 2013 Feb;20(2):367. doi: 10.1038/cdd.2012.137. Epub 2012 Nov 23.
7
Mapping of O-GlcNAc sites of 20 S proteasome subunits and Hsp90 by a novel biotin-cystamine tag.通过新型生物素-胱胺标签对 20S 蛋白酶体亚基和 Hsp90 的 O-GlcNAc 位点进行作图。
Mol Cell Proteomics. 2012 Aug;11(8):467-77. doi: 10.1074/mcp.M111.015966. Epub 2012 May 3.
8
Plk1 regulates the kinesin-13 protein Kif2b to promote faithful chromosome segregation.Plk1 通过调节驱动蛋白-13 家族成员 Kif2b 促进染色体的正确分离。
Mol Biol Cell. 2012 Jun;23(12):2264-74. doi: 10.1091/mbc.E11-12-1013. Epub 2012 Apr 25.
9
Synergistic effects of combination treatment with bortezomib and doxorubicin in human neuroblastoma cell lines.硼替佐米联合多柔比星治疗人神经母细胞瘤细胞系的协同作用。
Chemotherapy. 2012;58(1):44-51. doi: 10.1159/000335603. Epub 2012 Feb 11.
10
Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach.采用综合方法测定 26S 蛋白酶体全复合物的分子结构。
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1380-7. doi: 10.1073/pnas.1120559109. Epub 2012 Jan 23.